Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?
Authors
Keywords
Ataxia, Recessive, Riboflavin transporter deficiency, Treatment, Brown-Vialetto-Van Laere syndrome-2, BVVLS2, Pharmacokinetics, SLC52A2, Adult
Journal
PARKINSONISM & RELATED DISORDERS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2018-10-16
DOI
10.1016/j.parkreldis.2018.10.017

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.